Mathematical modeling of Clostridium difficile infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Laboratory diagnosis and biosafety issues of biological warfare agents

Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000–2012 M. Tvede,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Characteristics of Clostridium difficile strains isolated from asymptomatic individuals and from diarrheal patients S. Wongwanich, P. Pongpech, C. Dhiraputra,

J.-C. Lagier Clinical Microbiology and Infection

L. Boyanova Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis J.

Herpes zoster in non-hospitalized children

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Public health significance of invasive mosquitoes in Europe

Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Isospora belli infection in a patient with non-Hodgkin's lymphoma

Vector control: a cornerstone in the malaria elimination campaign

F.R. Gómez, E.P. de la Llave, J.M. García-Lechuz Moya

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Laboratory diagnosis and biosafety issues of biological warfare agents

H. Mieszczanska, B.A. Cunha, P.E. Schoch, E. Selbs, J.M. Lazar

M. Roche, H. Humphreys, E. Smyth, J. Phillips, R. Cunney, E

Sepsis and neutropenia induced by clozapine

Uncommon opportunistic fungi: new nosocomial threats

L. Fenner, A. F. Widmer, A. Stranden, M. Conzelmann, A. Goorhuis, C

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin King A. , Bathgate.

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

G.R. Davies Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Clinical microbiological case: poor radiologic evolution of pulmonary tuberculosis in a heart transplant patient F. Gavilán, J. Torre-Cisneros, M.A.

Brucella detection in blood: comparison of the BacT/Alert standard aerobic bottle, BacT/Alert FAN aerobic bottle and BacT/Alert enhanced FAN aerobic bottle.

R. Colebunders, P. Michielsen Clinical Microbiology and Infection

Campylobacter fetus pericarditis in a patient with β-thalassemia: case report and review of the literature S.S. Kanj, G.F. Araj, A. Taher, L.B. Reller

Community-acquired pneumonia: epidemiologic and clinical consideration

Training in infectious diseases and tropical medicine in Britain

Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women F. Auquer, F. Cordón, E. Gorina, J.C. Caballero,

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

V. Spoorenberg, J. M. Prins, B. C. Opmeer, T. M. de Reijke, M. E. J. L

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Microbiologic factors affecting Clostridium difficile recurrence

Evaluation of the performance of the Helico Blot 2

C.P. Kelly Clinical Microbiology and Infection

P. Muñoz, J. Palomo, J. Yáñez, E. Bouza

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

J.L. Balcázar Clinical Microbiology and Infection

Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,

Typing of Clostridium difficile

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

The future of diagnostic bacteriology

Presentation transcript:

Mathematical modeling of Clostridium difficile infection J.M. Starr, A. Campbell Clinical Microbiology and Infection Volume 7, Issue 8, Pages 432-437 (August 2001) DOI: 10.1046/j.1198-743x.2001.00291.x Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Markov chain Monte Carlo simulation of the number of Clostridium difficile toxin-positive diarrhea cases over time (days) with constant environmental contamination as the only reservoir of infection. Clinical Microbiology and Infection 2001 7, 432-437DOI: (10.1046/j.1198-743x.2001.00291.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Markov chain Monte Carlo simulation of the number of Clostridium difficile toxin-positive diarrhea cases over time (days) with constant environmental contamination and colonised patients as reservoirs of infection. Clinical Microbiology and Infection 2001 7, 432-437DOI: (10.1046/j.1198-743x.2001.00291.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Markov chain Monte Carlo simulation of the number of Clostridium difficile toxin-positive diarrhea cases over time (days) with constant environmental contamination and patients with toxin positive diarrhea as reservoirs of infection. Clinical Microbiology and Infection 2001 7, 432-437DOI: (10.1046/j.1198-743x.2001.00291.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions